United States Healthcare Providers & Services

Neogenomics Inc (NEO)

Track

Neogenomics Inc. has seen significant insider selling activity over the past 90 days, totaling approximately $3.94 million in sales. Notable transactions include a large proposed sale by a former affiliate in late July. These activities follow a period of strong stock performance, with the share price currently near its 52-week high.
Ticker: NEO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Neogenomics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 30 Jul 2026
Value US$991,214.40 | Price 495.41 | Shares 40,976
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-30 2026-07-30 PrS Proposed sale
3.4
JEFFREY SHERMAN

Former Affliate
40,976
495.41
US$991,214 		40,976 495.41 US$991,214
2026-06-17 2026-06-15 S Sale
2.8
TETRAULT LYNN A.
Non-Executive Director
20,401 -27.4%
174.60
US$2,558,747 		20,401 -27.4% 174.60 US$2,558,747
2026-06-15 2026-06-15 PrS Proposed sale
2.8
LYNN TETRAULT

Director

Non-Executive Director
19,170
18.22
US$2,137,025 		19,170 18.22 US$2,137,025
2026-06-11 2026-06-09 S Sale
2.8
TETRAULT LYNN A.
Non-Executive Director
5,307 -5.5%
11.29
US$59,916 		5,307 -5.5% 11.29 US$59,916
2026-06-09 2026-06-09 PrS Proposed sale
2.8
LYNN TETRAULT

Director

Non-Executive Director
5,307
10.95
US$58,112 		5,307 10.95 US$58,112
2026-01-21 2026-01-20 S Sale
3.0
Stone Warren

Pres & Chief Operating Officer

Officer
22,128 -15.4%
12.50
US$276,682 		22,128 -15.4% 12.50 US$276,682
2026-01-20 2026-01-20 PrS Proposed sale
3.0
WARREN STONE

Officer

Officer
22,128
12.79
US$283,017 		22,128 12.79 US$283,017
2025-11-28 2025-11-25 PlS Planned sale
1.8
Olivo Alicia C

EVP, GC & Business Development

Officer
20,916 -40.2%
12.00
US$250,992 		20,916 -40.2% 12.00 US$250,992
2025-11-25 2025-11-25 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
11,939
11.61
US$138,612 		11,939 11.61 US$138,612
2025-10-20 2025-10-16 PlS Planned sale
1.8
Olivo Alicia C

EVP, GC & Business Development

Officer
4,918 -10.3%
10.00
US$49,180 		4,918 -10.3% 10.00 US$49,180
2025-10-16 2025-10-16 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
4,918
9.97
US$49,032 		4,918 9.97 US$49,032
2025-08-06 2025-08-06 B Purchase
3.4
Sherman Jeffrey Scott

Chief Financial Officer

Officer
20,000 +11.9%
5.62
US$112,322 		20,000 +11.9% 5.62 US$112,322
2025-08-06 2025-08-06 B Purchase
3.1
Zook Anthony P.

Chief Executive Officer

Executive Director
17,900 +88.8%
5.58
US$99,954 		17,900 +88.8% 5.58 US$99,954
2025-05-28 2025-05-27 B Purchase
1.4
Kelly Michael Aaron
Non-Executive Director
5,000 +inf%
7.60
US$38,000 		5,000 +inf% 7.60 US$38,000
2025-05-13 2025-05-12 B Purchase
3.0
Stone Warren

Pres & Chief Operating Officer

Officer
5,700 +5.6%
8.58
US$48,895 		5,700 +5.6% 8.58 US$48,895
2025-05-09 2025-05-09 B Purchase
2.8
TETRAULT LYNN A.
Non-Executive Director
7,000 +inf%
8.14
US$56,974 		7,000 +inf% 8.14 US$56,974
2025-05-09 2025-05-07 B Purchase
1.4
KANOVSKY STEPHEN M
Non-Executive Director
4,000 +11.1%
7.78
US$31,124 		4,000 +11.1% 7.78 US$31,124
2025-05-08 2025-05-06 B Purchase
3.1
Zook Anthony P.

Chief Executive Officer

Executive Director
18,900 +inf%
7.88
US$148,919 		18,900 +inf% 7.88 US$148,919
2025-05-07 2025-05-05 B Purchase
1.5
Perez David Brian
Non-Executive Director
10,000 +inf%
7.63
US$76,300 		10,000 +inf% 7.63 US$76,300
2025-05-07 2025-05-05 B Purchase
1.5
Gunn Neil
Non-Executive Director
4,510 +39.8%
7.76
US$34,977 		4,510 +39.8% 7.76 US$34,977
2025-05-06 2025-05-02 PP Planned purchase
3.4
Sherman Jeffrey Scott

Chief Financial Officer

Officer
20,000 +14.4%
7.51
US$150,104 		20,000 +14.4% 7.51 US$150,104
2024-11-19 2024-11-15 PlS Planned sale
1.8
Olivo Alicia C

General Counsel

Officer
5,175 -12.2%
15.36
US$79,475 		5,175 -12.2% 15.36 US$79,475
2024-11-15 2024-11-15 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
5,175
15.79
US$81,713 		5,175 15.79 US$81,713
2024-08-19 2024-08-15 PlS Planned sale
1.8
Olivo Alicia C

General Counsel

Officer
1,040 -2.3%
16.05
US$16,695 		1,040 -2.3% 16.05 US$16,695
2024-08-15 2024-08-15 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
1,040
15.82
US$16,453 		1,040 15.82 US$16,453
2024-08-15 2024-08-15 PrS Proposed sale
1.7
BRUCE K CROWTHER

Officer; Director

Executive Director
8,353
15.95
US$133,243 		8,353 15.95 US$133,243
2024-05-28 2024-05-28 PrS Proposed sale
1.7
BRUCE K CROWTHER

Officer; Director

Executive Director
13,882
14.29
US$198,336 		13,882 14.29 US$198,336
2024-05-17 2024-05-15 S Sale
1.8
Olivo Alicia C

General Counsel

Officer
1,049 -2.3%
15.74
US$16,511 		1,049 -2.3% 15.74 US$16,511
2024-05-15 2024-05-15 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
1,049
15.40
US$16,155 		1,049 15.40 US$16,155
2024-03-06 2024-03-04 S Sale
2.8
TETRAULT LYNN A.
Non-Executive Director
6,112 -10.9%
15.97
US$97,579 		6,112 -10.9% 15.97 US$97,579
2024-03-04 2024-03-04 PrS Proposed sale
2.8
LYNN TETRAULT

Director

Non-Executive Director
6,112
15.97
US$97,609 		6,112 15.97 US$97,609
2024-02-20 2024-02-15 PlS Planned sale
1.8
Olivo Alicia C

General Counsel

Officer
2,587 -6.9%
14.96
US$38,713 		2,587 -6.9% 14.96 US$38,713
2024-02-15 2024-02-15 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
2,587
14.90
US$38,546 		2,587 14.90 US$38,546
2023-11-20 2023-11-17 PlS Planned sale
1.8
Olivo Alicia C

General Counsel

Officer
2,669 -6.7%
18.39
US$49,083 		2,669 -6.7% 18.39 US$49,083
2023-11-17 2023-11-17 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
2,669
17.97
US$47,962 		2,669 17.97 US$47,962
2022-03-09 2022-03-07 PlS Planned sale
2.0
Bonello William

Chief Financial Officer

Officer
3,209 -3.2%
18.29
US$58,693 		3,209 -3.2% 18.29 US$58,693
2021-12-23 2021-12-21 PlS Planned sale
McKenzie Kathryn B

Chief Financial Officer

Officer
1,846 -13.6%
35.00
US$64,610 		1,846 -13.6% 35.00 US$64,610
2021-12-06 2021-12-06 B Purchase
0.7
Mallon Mark

Chief Executive Officer

Executive Director
17,000 +30.5%
30.63
US$520,710 		17,000 +30.5% 30.63 US$520,710
2021-11-26 2021-11-26 PlS Planned sale
Brown Douglas Matthew

Chief Strategy Officer

Officer
33,334 -74.1%
36.85
US$1,228,358 		33,334 -74.1% 36.85 US$1,228,358
2021-11-29 2021-11-24 PlS Planned sale
2.0
Bonello William

President, Informatics

Officer
25,000 -61.8%
37.13
US$928,250 		25,000 -61.8% 37.13 US$928,250
2021-11-26 2021-11-24 PlS Planned sale
Brown Douglas Matthew

Chief Strategy Officer

Officer
33,333 -42.6%
36.84
US$1,227,988 		33,333 -42.6% 36.84 US$1,227,988
2021-11-26 2021-11-23 PlS Planned sale
Brown Douglas Matthew

Chief Strategy Officer

Officer
33,333 -29.9%
37.19
US$1,239,654 		33,333 -29.9% 37.19 US$1,239,654
2021-06-10 2021-06-08 S Sale
1.7
CROWTHER BRUCE K
Non-Executive Director
20,734 -29.5%
41.46
US$859,632 		20,734 -29.5% 41.46 US$859,632
2021-06-04 2021-06-03 S Sale
2.0
CARDOZA GEORGE

President, Pharma Services

Officer
31,107 -15.0%
40.11
US$1,247,702 		31,107 -15.0% 40.11 US$1,247,702
2021-06-04 2021-06-02 S Sale
2.0
CARDOZA GEORGE

President, Pharma Services

Officer
169,230 -44.9%
40.39
US$6,835,200 		169,230 -44.9% 40.39 US$6,835,200
2020-12-15 2020-12-14 S Sale
2.0
Weiss Lawrence Martin

Chief Medical Officer

Officer
20,200 -16.7%
51.06
US$1,031,412 		20,200 -16.7% 51.06 US$1,031,412
2020-12-14 2020-12-14 S Sale
2.6
JONES STEVEN C
Non-Executive Director
25,000 -2.4%
51.67
US$1,291,750 		25,000 -2.4% 51.67 US$1,291,750
2020-12-14 2020-12-11 S Sale
2.6
JONES STEVEN C
Non-Executive Director
25,000 -2.4%
50.52
US$1,263,000 		25,000 -2.4% 50.52 US$1,263,000
2020-12-11 2020-12-11 S Sale
2.3
BALLIET JENNIFER

VP and Chief Culture Officer

Officer
15,000 -37.5%
49.99
US$749,850 		15,000 -37.5% 49.99 US$749,850
2020-12-14 2020-12-10 S Sale
2.6
JONES STEVEN C
Non-Executive Director
20,000 -1.9%
50.30
US$1,006,000 		20,000 -1.9% 50.30 US$1,006,000
2020-12-07 2020-12-07 S Sale
2.6
JONES STEVEN C
Non-Executive Director
45,658 -4.1%
49.45
US$2,257,788 		45,658 -4.1% 49.45 US$2,257,788
2020-12-07 2020-12-04 S Sale
2.6
JONES STEVEN C
Non-Executive Director
64,394 -5.5%
48.07
US$3,095,420 		64,394 -5.5% 48.07 US$3,095,420
2020-12-07 2020-12-04 S Sale
1.5
Johnson Kevin C
Non-Executive Director
24,683 -44.3%
47.88
US$1,181,822 		24,683 -44.3% 47.88 US$1,181,822
2020-12-07 2020-12-03 S Sale
2.6
JONES STEVEN C
Non-Executive Director
19,948 -1.7%
48.03
US$958,102 		19,948 -1.7% 48.03 US$958,102
2020-12-04 2020-12-02 S Sale
2.0
Bonello William

President, Informatics

Officer
8,000 -39.9%
46.80
US$374,400 		8,000 -39.9% 46.80 US$374,400
2020-11-25 2020-11-25 S Sale
2.0
CARDOZA GEORGE

President, Pharma Services

Officer
77,074 -17.2%
45.48
US$3,505,326 		77,074 -17.2% 45.48 US$3,505,326
2020-11-25 2020-11-24 S Sale
2.0
CARDOZA GEORGE

President, Pharma Services

Officer
52,926 -12.5%
45.19
US$2,391,726 		52,926 -12.5% 45.19 US$2,391,726
2020-11-18 2020-11-16 S Sale
1.4
HIPP RAYMOND R
Non-Executive Director
70,000 -51.2%
42.28
US$2,959,600 		70,000 -51.2% 42.28 US$2,959,600
2020-11-16 2020-11-16 S Sale
0.9
VAN OORT DOUGLAS M

Chairman and CEO

Executive Director
100,000 -4.0%
42.34
US$4,234,000 		100,000 -4.0% 42.34 US$4,234,000
2020-11-16 2020-11-13 S Sale
0.9
VAN OORT DOUGLAS M

Chairman and CEO

Executive Director
118,752 -4.5%
41.56
US$4,935,333 		118,752 -4.5% 41.56 US$4,935,333
2020-11-16 2020-11-12 S Sale
0.9
VAN OORT DOUGLAS M

Chairman and CEO

Executive Director
121,248 -5.1%
42.18
US$5,114,241 		121,248 -5.1% 42.18 US$5,114,241
2020-11-12 2020-11-10 S Sale
0.6
Pedulla Denise E

General Counsel

Officer
2,262 -3.8%
42.00
US$95,004 		2,262 -3.8% 42.00 US$95,004
2020-09-24 2020-09-24 S Sale
1.7
CROWTHER BRUCE K
Non-Executive Director
8,333 -15.2%
35.01
US$291,738 		8,333 -15.2% 35.01 US$291,738
2020-09-24 2020-09-22 S Sale
1.7
CROWTHER BRUCE K
Non-Executive Director
2,400 -4.9%
35.68
US$85,632 		2,400 -4.9% 35.68 US$85,632
2020-09-10 2020-09-10 S Sale
2.6
JONES STEVEN C
Non-Executive Director
37,991 -2.7%
37.13
US$1,410,606 		37,991 -2.7% 37.13 US$1,410,606
2020-09-10 2020-09-09 S Sale
2.6
JONES STEVEN C
Non-Executive Director
71,583 -4.8%
36.98
US$2,647,139 		71,583 -4.8% 36.98 US$2,647,139
2020-09-10 2020-09-08 S Sale
2.6
JONES STEVEN C
Non-Executive Director
10,426 -0.7%
36.13
US$376,691 		10,426 -0.7% 36.13 US$376,691
2020-08-10 2020-08-06 S Sale
2.0
CARDOZA GEORGE

President, Pharma Services

Officer
82,500 -19.0%
39.35
US$3,246,375 		82,500 -19.0% 39.35 US$3,246,375
2020-08-04 2020-08-03 S Sale
2.0
Bonello William

President, Informatics

Officer
22,000 -64.6%
38.61
US$849,420 		22,000 -64.6% 38.61 US$849,420
2020-08-04 2020-08-03 S Sale
2.3
BALLIET JENNIFER

VP and Chief Culture Officer

Officer
13,000 -34.2%
39.25
US$510,250 		13,000 -34.2% 39.25 US$510,250
2020-08-03 2020-07-30 S Sale
2.4
SHOVLIN ROBERT J.

President, Clinical Services

Officer
81,356 -35.4%
38.17
US$3,105,359 		81,356 -35.4% 38.17 US$3,105,359
2020-03-05 2020-03-04 S Sale
2.4
SHOVLIN ROBERT J.

President, Clinical Services

Officer
98,093 -39.3%
30.86
US$3,027,150 		98,093 -39.3% 30.86 US$3,027,150
2020-03-04 2020-03-02 S Sale
2.6
JONES STEVEN C
Non-Executive Director
20,000 -39.6%
28.24
US$564,800 		20,000 -39.6% 28.24 US$564,800
2020-03-04 2020-03-02 S Sale
2.6
JONES STEVEN C
Non-Executive Director
2,300 -5.3%
28.24
US$64,952 		2,300 -5.3% 28.24 US$64,952
2020-03-04 2020-03-02 S Sale
2.6
JONES STEVEN C
Non-Executive Director
25,000 -16.7%
28.48
US$712,000 		25,000 -16.7% 28.48 US$712,000
Explore more

More insider trading research around Neogenomics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America